跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,487 条关于
“Olanzapine LAI”
全部
4,487
临床试验
1,870
药物
338
机构
180
资讯
2,099
去年
Teva's Olanzapine LAI Shows Positive Phase 3 Results for Schizophrenia
12个月前
Teva's Olanzapine LAI Shows No PDSS Events in 56-Week Phase 3 Trial, Paving Way for First Long-Acting Olanzapine Treatment
去年
Olanzapine LAI Shows Promise in Schizophrenia Treatment with Improved Safety Profile
去年
MedinCell's Olanzapine LAI Phase 3 Trial Completes, Triggering $5M Milestone Payment from Teva
2个月前
Phase 3 SOLARIS Trial: Subcutaneous Olanzapine LAI Demonstrates Efficacy Without PDSS in Schizophrenia
6个月前
Medincell Raises Capital to Advance Long-Acting Injectable Platform and Expand Partnerships
17天前
Medincell Appoints Edna Venneker, MD, as Chief Medical Officer
去年
Teva Raises UZEDY Revenue Outlook to $190-200M as Medincell's Olanzapine Injectable Advances Toward FDA Filing
去年
Teva Unveils $5 Billion Growth Strategy with Five Potential Blockbuster Drugs in Late-Stage Pipeline
去年
Teva's TEV-749 Shows Promise in Schizophrenia Treatment with No PDSS Incidence
第 1 页,共 210 页
上一页
下一页